Yingting. Mok, et.al., MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production., Journal of immunology (Baltimore, Md. : 1950), 2013, 191

http://rdf.ncbi.nlm.nih.gov/pubmed/23960236

Yingting. Mok, et.al., MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production., Journal of immunology (Baltimore, Md. : 1950), 2013, 191

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/db/mgi_rdf/MGI:5555968
• Mir210<tm1.1Wtsi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5555932

class

http://purl.org/net/cito/citesAsAuthority

• Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/db/mgi_rdf/MGI:5555968
• Mir210<tm1.1Wtsi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5555932

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased anti-chromatin antibody level_Mir210<tm1.1Wtsi>/Mir210<tm1.1Wtsi>
  http://metadb.riken.jp/0004829IC57BL6JC57BL6NMir210tm11WtsiMir210tm11WtsiMir210tm11Wtsi
• abnormal class switch recombination_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0004816B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased marginal zone B cell number_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008182B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased IgG3 level_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008498B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• increased anti-double stranded DNA antibody level_Mir210<tm1.1Wtsi>/Mir210<tm1.1Wtsi>
  http://metadb.riken.jp/0004762IC57BL6JC57BL6NMir210tm11WtsiMir210tm11WtsiMir210tm11Wtsi
• decreased IgA level_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0001807B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased pre-B cell number_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008209B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased IgG2b level_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008497B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased IgG1 level_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008495B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• increased B-1a cell number_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008167B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased germinal center B cell number_Mir210<tm1.1Wtsi>/Mir210<tm1.1Wtsi>
  http://metadb.riken.jp/0008178IC57BL6JC57BL6NMir210tm11WtsiMir210tm11WtsiMir210tm11Wtsi
• increased anti-nuclear antigen antibody level_Mir210<tm1.1Wtsi>/Mir210<tm1.1Wtsi>
  http://metadb.riken.jp/0004794IC57BL6JC57BL6NMir210tm11WtsiMir210tm11WtsiMir210tm11Wtsi
• decreased IgG2a level_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008496B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• abnormal spleen marginal zone morphology_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0002362B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased pro-B cell number_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008208B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs
• decreased mature B cell number_Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
  http://metadb.riken.jp/0008211B6CgTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcsTgIghMir210aKgcs